Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

Jemal, 2010, Global patterns of cancer incidence and mortality rates and trends, Cancer Epidemiol Biomarkers Prev, 19, 1893, 10.1158/1055-9965.EPI-10-0437 Oeppen, 2002, Demography. Broken limits to life expectancy, Science, 296, 1029, 10.1126/science.1069675 Gasic, 1968, Antimetastatic effects associated with platelet reduction, Proc Natl Acad Sci USA, 61, 46, 10.1073/pnas.61.1.46 Gasic, 1972, Anti-metastatic effect of aspirin, Lancet, 300, 932, 10.1016/S0140-6736(72)92581-0 Wang, 2006, Prostaglandins and cancer, Gut, 55, 115, 10.1136/gut.2004.047100 Doherty, 2009, Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?, Expert Opin Ther Targets, 13, 209, 10.1517/14728220802653631 Hung, 2008, Anti-metastatic action of non-steroidal anti-inflammatory drugs, Kaohsiung J Med Sci, 24, 392, 10.1016/S1607-551X(08)70162-1 Ruschoff, 1998, Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection, Proc Natl Acad Sci USA, 95, 11301, 10.1073/pnas.95.19.11301 McIlhatton, 2007, Nitric oxide-donating aspirin derivatives suppress microsatellite instability in mismatch repair-deficient and hereditary nonpolyposis colorectal cancer cells, Cancer Res, 67, 10966, 10.1158/0008-5472.CAN-07-2562 Elwood, 2009, Aspirin, salicylates, and cancer, Lancet, 373, 1301, 10.1016/S0140-6736(09)60243-9 Bosetti, 2009, Aspirin and cancer risk: a summary review to 2007, Recent Results Cancer Res, 181, 231, 10.1007/978-3-540-69297-3_22 Rothwell, 2010, Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials, Lancet, 376, 1741, 10.1016/S0140-6736(10)61543-7 Rothwell, 2011, Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials, Lancet, 377, 31, 10.1016/S0140-6736(10)62110-1 Flossmann, 2007, Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies, Lancet, 369, 1603, 10.1016/S0140-6736(07)60747-8 Rothwell, 2012, Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in randomised controlled trials, Lancet, 10.1016/S0140-6736(11)61720-0 Rothwell, 2012, Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials, Lancet Cuzick, 2009, Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement, Lancet Oncol, 10, 501, 10.1016/S1470-2045(09)70035-X 2007, Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 146, 361, 10.7326/0003-4819-146-5-200703060-00008 Farquhar, 2005, Long term hormone therapy for perimenopausal and postmenopausal women, Cochrane Database Syst Rev, 3, 10.1002/14651858.CD004143.pub2 Lawlor, 2004, Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?, Lancet, 363, 1724, 10.1016/S0140-6736(04)16260-0 Flossmann, 2007, Commentary: aspirin and colorectal cancer an epidemiological success story, Int J Epidemiol, 36, 962, 10.1093/ije/dym200 1998, Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk, Lancet, 351, 233, 10.1016/S0140-6736(97)11475-1 Peto, 1988, Randomised trial of prophylactic daily aspirin in British male doctors, Br Med J (Clin Res Ed), 296, 313, 10.1136/bmj.296.6618.313 Farrell, 1991, The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results, J Neurol Neurosurg Psychiatry, 54, 1044, 10.1136/jnnp.54.12.1044 Cole, 2009, Aspirin for chemoprevention of colorectal adenomas: meta-analysis of the randomised trials, J Natl Cancer Inst, 101, 256, 10.1093/jnci/djn485 Chan, 2005, Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer, JAMA, 294, 914, 10.1001/jama.294.8.914 Chan, 2008, Aspirin dose and duration of use and risk of colorectal cancer in men, Gastroenterology, 134, 21, 10.1053/j.gastro.2007.09.035 Jacobs, 2007, A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence, J Natl Cancer Inst, 99, 608, 10.1093/jnci/djk132 Vinogradova, 2007, Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study, Gastroenterology, 133, 393, 10.1053/j.gastro.2007.05.023 Thun, 1991, Aspirin use and reduced risk of fatal colon cancer, N Engl J Med, 325, 1593, 10.1056/NEJM199112053252301 Suleiman, 2000, H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case–control study, Eur J Cancer Prev, 9, 185, 10.1097/00008469-200006000-00006 Ratnasinghe, 2004, Aspirin use and mortality from cancer in a prospective cohort study, Anticancer Res, 24, 3177 Sharpe, 2000, Nested case–control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage, Br J Cancer, 83, 112, 10.1054/bjoc.2000.1119 Menezes, 2006, Regular use of aspirin and prostate cancer risk (United States), Cancer Causes Control, 17, 251, 10.1007/s10552-005-0450-z Leitzmann, 2002, Aspirin use in relation to risk of prostate cancer, Cancer Epidemiol Biomarkers Prev, 11, 1108 Sansbury, 2005, Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case–control study of African Americans and Whites, Am J Epidemiol, 162, 548, 10.1093/aje/kwi248 Rosenberg, 1998, Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma, Cancer, 82, 2326, 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q Blair, 2007, NSAID use and survival after breast cancer diagnosis in post-menopausal women, Breast Cancer Res Treat, 101, 191, 10.1007/s10549-006-9277-x Kwan, 2007, NSAIDs and breast cancer recurrence in a prospective cohort study, Cancer Causes Control, 18, 613, 10.1007/s10552-007-9003-y Chan, 2009, Aspirin use and survival after diagnosis of colorectal cancer, JAMA, 302, 649, 10.1001/jama.2009.1112 Burn, 2011, Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial, Lancet, 378, 2081, 10.1016/S0140-6736(11)61049-0 Chan, 2012, Aspirin in the chemoprevention of colorectal neoplasia: an overview, Cancer Prev Res, 5, 164, 10.1158/1940-6207.CAPR-11-0391 Cook, 2005, Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial, JAMA, 294, 47, 10.1001/jama.294.1.47 1989, Final report on the aspirin component of the ongoing Physicians’ Health Study, N Engl J Med, 321, 129, 10.1056/NEJM198907203210301 Seshasai, 2012, Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials, Arch Intern Med, 172, 209, 10.1001/archinternmed.2011.628